BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 18355849)

  • 1. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Chi A; Gupta A; Snodgrass W
    J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
    Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
    J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
    Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC
    J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid.
    Sedberry-Ross S; Rice DC; Pohl HG; Belman AB; Majd M; Rushton HG
    J Urol; 2008 Oct; 180(4 Suppl):1605-9; discussion 1610. PubMed ID: 18710762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux.
    Kajbafzadeh AM; Tourchi A
    J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction.
    Läckgren G; Sköldenberg E; Stenberg A
    J Urol; 2007 Mar; 177(3):1124-8; discussion 1128-9. PubMed ID: 17296428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Yucel S; Gupta A; Snodgrass W
    J Urol; 2007 Apr; 177(4):1505-9. PubMed ID: 17382765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.